JVT Tilsed, A Casamassima, H Kurihara… - European Journal of …, 2016 - Springer
Purpose Acute mesenteric ischaemia (AMI) accounts for about 1: 1000 acute hospital admissions. Untreated, AMI will cause mesenteric infarction, intestinal necrosis, an …
L Pironi, J Arends, F Bozzetti, C Cuerda, L Gillanders… - Clinical nutrition, 2016 - Elsevier
Summary Background & aims Chronic Intestinal Failure (CIF) is the long-lasting reduction of gut function, below the minimum necessary for the absorption of macronutrients and/or water …
L Pironi, J Arends, J Baxter, F Bozzetti, RB Peláez… - Clinical nutrition, 2015 - Elsevier
Background & aims Intestinal failure (IF) is not included in the list of PubMed Mesh terms, as failure is the term describing a state of non functioning of other organs, and as such is not …
L Pironi, C Cuerda, PB Jeppesen, F Joly, C Jonkers… - Clinical Nutrition, 2023 - Elsevier
Background & aims In 2016, ESPEN published the guideline for Chronic Intestinal Failure (CIF) in adults. An updated version of ESPEN guidelines on CIF due to benign disease in …
Short bowel syndrome (SBS) is a rare malabsorptive disorder as a result of the loss of bowel mass mostly secondary to surgical resection of the small intestine. Other causes are …
RH Squires, C Duggan, DH Teitelbaum… - The Journal of …, 2012 - Elsevier
OBJECTIVE: To characterize the natural history of intestinal failure (IF) among 14 pediatric centers during the intestinal transplantation era. STUDY DESIGN: The Pediatric Intestinal …
L Pironi - Best practice & research Clinical gastroenterology, 2016 - Elsevier
Abstract The European Society for Clinical Nutrition and Metabolism defined intestinal failure (IF) as “the reduction of gut function below the minimum necessary for the absorption …
Objectives: To identify predictive factors for irreversible transmural intestinal necrosis (ITIN) in acute mesenteric ischemia (AMI) and establish a risk score for ITIN. Methods: This single …
PB Jeppesen, R Gilroy, M Pertkiewicz, JP Allard… - Gut, 2011 - gut.bmj.com
Background and aims Teduglutide, a GLP-2 analogue, may restore intestinal structural and functional integrity by promoting repair and growth of the mucosa and reducing gastric …